A Pharmacodynamic and Pharmacokinetic Study of RO5508887 in Healthy Volunteers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This randomized, double-blind, placebo-controlled, parallel group study will evaluate the pharmacodynamics and pharmacokinetics of RO5508887 in healthy volunteers. Subjects will be randomized in cohorts to receive single oral doses of either RO5508887 or placebo. In-unit period is 6 days.
Epistemonikos ID: dadabec497b10c994bb2162a6c0c092d5f98d5f9
First added on: May 10, 2024